InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (5 ops.)
Explore the complete record of transactions filed by Bonstein Sara, Chief Financial Officer. Officer active across 3 companies, notably INSMED Inc. Aggregated, 10 filings have been logged. Total volume traded: €1.7m. The latest transaction was disclosed on 13 May 2026 — Cession. Regulator: SEC (Form 4). The full history is openly available.
Declarations10 total
€820,2778,272 shares@ €99.16310.0022% mcap97.0% of flow
Common Stock
SEC:0001604019-26-000008·
€820,2778,272 shares@ €99.16310.0022% mcap94.1% of flow
Common Stock
SEC:0001604019-26-000008:0·
€25,4091,433 shares@ €17.73170.0001% mcap2.9% of flow
Common Stock
SEC:0001140361-22-019783:0·
20,137 shares
Common Stock
SEC:0001140361-22-019172:0·
€25,5741,154 shares@ €22.16160.0001% mcap3.0% of flow
Common Stock
SEC:0001140361-22-001602·
€25,5741,154 shares@ €22.16160.0001% mcap2.9% of flow
Common Stock
SEC:0001140361-22-001602:0·
13,006 shares
Common Stock
SEC:0001140361-22-001165·
13,006 shares
Common Stock
SEC:0001140361-22-001165:0·
14,172 shares
Common Stock
SEC:0001140361-21-017464·
14,172 shares
Common Stock
SEC:0001140361-21-017464:0·
10 of 10 declarations
About Bonstein Sara
Sara Bonstein is the Chief Financial Officer at INSMED Inc. She is responsible for the company's financial management, including financial planning and analysis. Bonstein plays a crucial role in developing financial strategies that support INSMED's objectives. Her expertise in finance and accounting is essential for ensuring the company's financial health.
